Join the 'Radium 223 Dichloride' group to help and get support from people like you.
Radium 223 Dichloride News
Posted 8 Sep 2014 by Drugs.com
MONDAY, Sept. 8, 2014 – Men newly diagnosed with prostate cancer often turn first to testosterone-depleting therapies, since male hormones help prostate tumors grow. But, those therapies almost always fail over time as the tumor develops resistance, according to oncologists. Now, experts are issuing updated guidelines to help patients in this situation decide what to do next. The guidelines, issued jointly by the American Society of Clinical Oncology (ASCO) and Cancer Care Ontario (CCO) in Canada, highlight recent advances in treating this more advanced form of prostate cancer. "We have seen unprecedented progress against advanced prostate cancer recently, with six new treatments approved in the last couple of years," Dr. Ethan Basch, co-chair of the ASCO/CCO panel of experts that developed the guidelines, said in a news release from the two groups. "There are a lot of nuances about ... Read more
Related support groups: Prostate Cancer, Ketoconazole, Zytiga, Nizoral, Casodex, Taxotere, Xtandi, Bicalutamide, Provenge, Docetaxel, Abiraterone, Xofigo, Flutamide, Cabazitaxel, Jevtana, Sipuleucel-t, Radium 223 Dichloride, Nilandron, Docefrez, Mitoxantrone